Alkermes PLC Sustainability Reports

Alkermes plc is a fully integrated global biopharmaceutical company that designs, develops, and commercializes innovative medicines for central nervous system disorders and neuroscience. Its commercial portfolio and clinical pipeline address conditions such as schizophrenia, bipolar I disorder, alcohol dependence, opioid dependence, and narcolepsy.

Sector: Manufacturing

Country: Ireland

Exchange: Nasdaq

ISIN: IE00B56GVS15

13 reports from 2015 to 2024

• Alkermes PLC 2024 Corporate Responsibility Report
• Alkermes PLC 2024 Annual Report
• Alkermes PLC 2023 Task Force on Climate-related Financial Disclosure (TCFD) Statement
• Alkermes PLC 2023 Directors' Report and Consolidated Financial Statements
• Alkermes PLC 2023 Corporate Responsibility Report